Open AccessMicrovascular invasion may be the determining factor in selecting TACE as the initial treatment in patients with hepatocellular carcinoma
Author(s) -
Joonho Jeong,
Jung Gu Park,
Kwang Ill Seo,
Ji Hyun Ahn,
Jae Chun Park,
Byung Cheol Yun,
Sang Uk Lee,
Jin Wook Lee,
Jong Hyouk Yun
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000026584
Subject(s) - medicine , hepatocellular carcinoma , univariate analysis , hepatectomy , transcatheter arterial chemoembolization , gastroenterology , multivariate analysis , necrosis , radiology , oncology , surgery , resection
The aim of this study was to investigate factors affecting tumor necrosis with transcatheter arterial chemoembolization (TACE). Factors associated with early hepatocellular carcinoma recurrence after curative hepatectomy were also evaluated. Data of 51 patients who underwent surgery after a single session of TACE at a single university hospital were retrospectively analyzed. Factors that might affect tumor necrosis were determined by evaluating the TACE approach and by analyzing computed tomography and TACE findings, pathologic reports, and laboratory findings. In univariate analysis, microvascular invasion (MVI), radiological capsule appearance on the computed tomography, chronic hepatitis B, diabetes mellitus and serum albumin, MVI were significantly associated with tumor necrosis by TACE ( P < .02). In multivariate analysis, MVI was the only statistically significant factor in TACE-induced tumor necrosis ( P = .001). In univariate and multivariate analysis, MVI was the strongest factor for recurrence-free survival rate within 2 years ( P = .008, P = .002). MVI could be a crucial factor in determining TACE as an initial treatment for hepatocellular carcinoma. MVI is also a strong indicator of recurrence within 2 years after curative hepatic resection.